LUNG - Pulmonx Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - LUNG (1127537)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

33 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-11-18
LUNGFrench Glendon E. IIIPres, CEOS - Sale$35.98-25,0001,105,370-2%-$899,471
2021-11-15
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$39.94-7,000145,814-5%-$279,580
2021-10-21
LUNGFrench Glendon E. IIIPres, CEOS - Sale$39.75-25,0001,130,370-2%-$993,681
2021-10-15
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$39.44-7,000152,814-4%-$276,080
M
2021-09-20
LUNGSung DerrickCFOS - Sale$37.43-6,000231,803-3%-$224,562
M
2021-09-16
LUNGFrench Glendon E. IIIPres, CEOS - Sale$38.13-48,5711,155,370-4%-$1,852,124
2021-09-15
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$38.12-7,000159,814-4%-$266,840
2021-09-01
LUNGSung DerrickCFOS - Sale$40.09-383237,8030%-$15,354
2021-09-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$40.09-355166,8140%-$14,232
2021-09-01
LUNGLehman David AaronGCS - Sale$40.09-38317,217-2%-$15,354
2021-09-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale$40.09-1,4211,203,9410%-$56,968
2021-08-19
LUNGFrench Glendon E. IIIPres, CEOS - Sale$36.63-26,0001,205,362-2%-$952,340
2021-08-16
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$36.71-7,000166,885-4%-$256,970
2021-07-15
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$38.73-7,000173,885-4%-$271,080
D
2021-07-15
LUNGFrench Glendon E. IIIPres, CEOS - Sale+OE$38.73-26,0001,231,305-2%-$1,006,906
2021-07-13
LUNGBoston Scientific Corp10%S - Sale$37.45-2,500,0001,488,106-63%-$93,625,000
2021-07-12
LUNGFlorin Daniel PDirP - Purchase$40.00+2,50023,321+12%+$100,000
2021-06-25
LUNGFlorin Daniel PDirP - Purchase$44.12+2,22220,821+12%+$98,035
D
2021-06-17
LUNGFrench Glendon E. IIIPres, CEOS - Sale+OE$42.95-26,0001,252,930-2%-$1,116,585
2021-05-24
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$40.88-4,797163,285-3%-$196,085
2021-05-20
LUNGFrench Glendon E. IIIPres, CEOS - Sale$41.91-26,0001,226,455-2%-$1,089,530
2021-05-10
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$40.70-4,797116,673-4%-$195,247
2021-04-19
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$43.24-4,797121,470-4%-$207,422
2021-04-15
LUNGFrench Glendon E. IIIPres, CEOS - Sale$43.75-26,0001,252,455-2%-$1,137,556
2021-04-06
LUNGBoston Scientific Corp10%S - Sale$43.60-650,0003,988,106-14%-$28,340,000
A
2021-04-05
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$47.65-4,797104,267-4%-$228,557
2021-04-05
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$47.64-4,797109,064-4%-$228,521
M
2021-04-05
LUNGSung DerrickCFOS - Sale$47.36-10,000218,659-4%-$473,622
2021-03-30
LUNGBoston Scientific Corp10%S - Sale$40.80-1,350,0004,638,106-23%-$55,080,000
2020-10-05
LUNGFlorin Daniel PDirP - Purchase$19.00+15,78915,789New+$299,991
D
2020-10-05
LUNGFerrari Richard MDirP - Purchase$19.00+13,1571,248,508+1%+$249,983
2020-10-05
LUNGMelenikiotou GeorgiaDirP - Purchase$19.00+26,31526,315New+$499,985
D
2020-10-05
LUNGMead Dana G Jr.DirP - Purchase$19.00+26,3151,550,424+2%+$499,985

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top